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PregnancyAbstract The use of antenatal corticosteroids is associated with reduction in morbidity and mor-
tality rates in preterm delivery. A 34 year-old pregnant woman, gravida 2 para1, was planned for
elective cesarean section at 36 weeks of gestation as ultrasound study showed intrauterine growth
retardation. She has idiopathic thrombocytopenia and anemia, with suspected hypoplastic anemia.
Due to mother’s low platelet count, antenatal intramuscular corticosteroids injection was avoided.
Instead, oral dexamethasone was given for fetal lung maturity. Baby’s Apgar score at 1-min and
5-min was 9 and 10, respectively. The baby girl did not develop respiratory distress syndrome.
She had mild transient tachypnea of newborn that needed only mild respiratory support with nasal
cannula in room air.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The antenatal maternal administration of corticosteroids has
been known for years to reduce morbidity and mortality rates
in preterm delivery. Risks of neonatal death and respiratory
distress syndrome (RDS) are reduced by 31% and 44%,
respectively, after a single course of antenatal corticosteroids.
Furthermore, neonatal complications such as intraventricular
hemorrhage, necrotising enterocolitis, and systemic infection
within ﬁrst 48 h of life are also reduced (Roberts and
Dalziel, 2006; Miracle et al., 2008).
The Royal College of Obstetrics and Gynecology (RCOG)
recommends antenatal corticosteroids to all women at risk of
preterm birth up to 34 + 6 weeks of gestation, as well as to
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prior to 38 + 6 weeks of gestation. The most extensively
studied regimens to prevent RDS are betamethasone 12 mg
for two doses 24 h apart and dexamethasone 6 mg for four
doses 12 h apart, both given intramuscularly (Royal College
of Obstetricians and Gynaecologists, 2010).
Intramuscular route of administration ofmedications is con-
traindicated when there is an extremely elevated risk of bleeding
(Surbek et al., 2012; Betamethasone, 2010). Although intra-
venous antenatal corticosteroids can be given, their clinical efﬁ-
cacy has not been studied, while the oral administration is
relatively obsolete (Surbek et al., 2012). In the only randomized
trial comparing antenatal intramuscular dexamethasone with
oral dexamethasone, RDS rate was similar between the two
groups, whereas higher rates of sepsis and intraventricular
hemorrhage reported in infants of mothers who received oral
dexamethasone (Egerman et al., 1998; Hodnett, 1999).
There are limited data about the optimum route of
administration for antenatal corticosteroids, when intra-
muscular route is not favorable. This case report presents
our experience with the use of antenatal oral dexamethasone
for a woman with idiopathic thrombocytopenia (ITP) and
the neonatal outcomes.
2. Ethical consideration
This is a retrospective case description report. A waiver of
informed consent and ethical approval were obtained from
Hamad Medical Research Center, Hamad Medical
Corporation, Qatar.
3. Case description
3.1. Mother
A 34 year-old pregnant woman, presented to the emergency
department with labor like pain at 35 + weeks of gestation.
She is gravid 2 para 1 with previous uncomplicated normal
vaginal delivery. She is a case of ITP and anemia, with sus-
pected hypoplastic anemia, received blood transfusion during
this pregnancy and currently on iron supplement, otherwise
she is healthy. She denies smoking and alcohol intake. She
was admitted to hospital as threatened preterm labor and to
put her delivery plan.
Her recent anemia workup on admission showed low hemo-
globin (Hgb) level (7.1 g/dl) and low platelet count (27 · 103/
ll, platelet estimation in P.B smear 30 · 103/ll). The hematolo-
gist ordered 2 units of blood and IVIG at a dose of 0.5 g/
kg/day for 4 days. Hemoglobin level after 6 h of transfusion
increased initially to 8.3 g/dl; then dropped to 7.8 g/dl when
rechecked again after IVIG completion, while platelet count
remained around the same 22 · 10 * 3/ll. One day after, the
day before delivery, Hgb 8.6 g/dl, platelet 25 · 103/ll with
P.B smear 33 · 103/ll.
During current hospitalization, ultrasound with Doppler
study showed a 5 weeks lag in growth with no growth in fetal
abdominal circumference since last two weeks scan.
Accordingly, diagnosis of intrauterine growth retardation
(IUGR) was made.
The mother and family were counseled regarding mode of
delivery and risk associated, with avoidance of operativevaginal delivery that is associated with increased hemorrhagic
risk to fetus. They opted for an elective cesarean section, which
was scheduled at 36 weeks of gestation.
No amniocentesis was done to check for fetal lung maturity
as it is not part of the routine practice at our hospital. RCOG
guideline recommends antenatal corticosteroids for preterm
elective cesarean section. Dexamethasone tablets were admi-
nistered orally instead of the intramuscular injection. The
administered oral dose was 8 mg every 12 h for total of 4
doses, and the last dose was completed about 3:30 h before
the surgery. The blood and blood products were transfused
as per the hematologist orders.
3.2. Baby
A baby girl was born to a 34 year-old multigravida mother,
with ITP and antenatal ultrasound that revealed IUGR.
Baby was born at 36 weeks of gestation with weight 2235 g.
The 1-min and 5-min Apgar scores were 9 and 10, respectively.
At age of 1-h, baby had mild grunting which was controlled
with incubator care with supplemental oxygen 2 L/min for one
hour in the postnatal ward. Again at age of 6-h, baby devel-
oped mild respiratory distress with mild grunting and retrac-
tion and was admitted to neonatal ward.
On examination in the neonatal intensive care unit (NICU),
the baby was still grunting, and chest examination revealed
equal air entry bilaterally, with mild subcostal retraction.
Heart sounds were normal, without murmurs, and the remain-
ders of systemic examinations were normal for her gestational
age. Oxygen saturation in room air was 94–95%, while the res-
piratory rate 64/min, temperature 36.6 C, heart rate 148/min,
and blood pressure 65/35 mmHg. Baby was suspected to have
Transient Tachypnea of Newborn (TTN) and kept under nasal
cannula 2 L ﬂow/min in room air for one day and gradually
weaned and discontinued on the third day. Baby developed
neonatal jaundice on the second day of life and needed pho-
totherapy for two days. Baby’s general condition improved
on the second day and feeding was started and gradually
increased to full feed by third day of life and the baby was dis-
charged home on the fourth day of life. Her chest X-ray
showed features suggestive of TTN and the complete blood
counts and serum electrolytes were normal, and blood culture
was negative (Table 1).4. Discussion
This case report presents our experience with the use of
antenatal oral dexamethasone for fetal lung maturity and the
neonatal outcomes. The intramuscular administration of
corticosteroids comprises the international, evidence-based
standard, where the intravenous and oral routes are neglected.
We preferred to void the use of intramuscular injection to
avoid the associated risk of hematoma, as the patient had a
low platelet count (22 · 103/ll).
There is no enough understanding for the clinical efﬁcacy of
intravenous antenatal corticosteroids, as it has not been evalu-
ated in studies (Surbek et al., 2012). Oral route of antenatal
corticosteroid has been evaluated in one study. Pregnant women
(n= 170) at high risk for preterm delivery between 24 and
33 weeks’ gestation were prospectively randomized to receive
either 8 mg oral dexamethasone or 6 mg intramuscular
Table 1 Baby laboratory data.
Date Reference range – age
adjusted
8 h of
age
20 h of
age
22 h of
age
32 h of
age
44 h of
age
Complete blood counts
Hematocrit (%) 45 – 65 58.0
Hemoglobin (g/dl) 14 – 22 20.8
Platelet (·103/ll) 100 – 450 146
White blood cells (·103/ll) 10 – 26 13.8
Neutrophils (·103/ll) 4 – 14 9.7
Lymphocytes (·103/ll) 3 – 8 2.2
Monocytes (·103/ll) 0.5 – 2 1.7
Eosinophils (·103/ll) 0.1 – 1 0.0
Basophil (·103/ll) 0.02 – 0.1 0.03
Serum electrolytes and others
Glucose (mmol/L) 3.2 – 6.1 3.8 4 4.9
Sodium (mmol/L) 135 – 145 141 146 141
Potassium (mmol/L) 3.7 – 5.9 6.4a 4.3 4.5
Chloride (mmol/L) 96 – 110 106 109 103
Calcium (mmol/L) 2.1 – 2.64 1.88 1.91 2.3
Urea nitrogen (mmol/L) 1.1 – 6.1 7.2 3.9
Serum creatinine (lmol/L) 44 – 80 55 52
Albumin (g/L) 27 – 43 33 36
Total bilirubin (mmol/L) 0 – 87 114 158 142 122
Direct bilirubin (mmol/L) 13 – 29 21
C-reactive protein (mg/l) <5 23
Blood culture Negative
Blood gas analysis
Type of specimen (capillary)
Fraction of inspired oxygen – 21% 21% 21% 21% 21%
pH 7.35 – 7.45 7.31 7.29 7.34 7.36 7.34
Partial pressure of carbon
dioxide (mmHg)
35 – 45 44.1 53 46 43 42
Partial pressure of oxygen
(mmHg)
50 – 70 52.2 48 49 49.2 62
Bicarbonate (mmol/L) 20 – 24 20.7 18.7 22.8 22.6 22.2
Base excess 4 to +4 4.3 5 1.1 1.9 2.1
a Sample was slightly hemolyzed, and degree of hemolysis most likely has increased potassium result by 0.3 mmol/L.
718 D. AlSaad et al.dexamethasone, both every 12 h for 4 doses and repeatedweekly
until 34 weeks’ gestation or until delivery if occurred earlier. The
main outcome was neonatal RDS. At 39% enrollment (170
patients), the study was discontinued after a blinded review of
available outcomes. RDS frequency was similar between the
oral group (34.3%) and intramuscular group (29.8%),
p= 0.53. Infants of women who received oral dexamethasone
had higher rates of sepsis (10.1% vs. 1.2%, p= 0.01) and intra-
ventricular hemorrhage (10.1% vs. 2.4%, p= 0.04), compared
to intramuscular group. There is no ready pharmacokinetic
explanation for the observed differences between the two routes.
Accordingly, the study concluded that until clear evidence
exists, the oral administration cannot be recommended
(Egerman et al., 1998; Hodnett, 1999).
In this case report, the neonatal outcomes after oral
administration of antenatal corticosteroid showed mild TTN
which may be seen in babies born by cesarean section. The baby
needed only mild respiratory support with nasal cannula in
room air for few days. The baby had mild jaundice, with no
other neonatal complications. Baby did not develop respiratory
distress syndrome due to surfactant deﬁciency and this might be
due to improvement in lung maturity contributed by thepositive effect of the oral corticosteroids, as the baby was deliv-
ered at 36 weeks of gestation by elective cesarean section.
In conclusion, this case report shows that antenatal oral
corticosteroid was effective in preventing respiratory distress
syndrome in a baby born at near term by elective cesarean
section.
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